Kimberly Gentile
2018
In 2018, Kimberly Gentile earned a total compensation of $2.8M as SVP, Clinical Operations at Biohaven Pharmaceutical Holding Co Ltd..
Compensation breakdown
| Bonus | $198,297 |
|---|---|
| Option Awards | $2,243,800 |
| Salary | $327,250 |
| Other | $15,192 |
| Total | $2,784,539 |
Gentile received $2.2M in option awards, accounting for 81% of the total pay in 2018.
Gentile also received $198.3K in bonus, $327.3K in salary and $15.2K in other compensation.
Rankings
In 2018, Kimberly Gentile's compensation ranked 4,185th out of 14,244 executives tracked by ExecPay. In other words, Gentile earned more than 70.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,185 out of 14,244 | 71st |
Division Manufacturing | 1,546 out of 5,758 | 73rd |
Major group Chemicals And Allied Products | 553 out of 2,119 | 74th |
Industry group Drugs | 463 out of 1,808 | 74th |
Industry Pharmaceutical Preparations | 359 out of 1,382 | 74th |
Source: SEC filing on April 11, 2019.
Gentile's colleagues
We found four more compensation records of executives who worked with Kimberly Gentile at Biohaven Pharmaceutical Holding Co Ltd. in 2018.
2018
Vlad Coric
Biohaven Pharmaceutical Holding Co Ltd.
Chief Executive Officer
2018
James Engelhart
Biohaven Pharmaceutical Holding Co Ltd.
Chief Financial Officer
2018
Charles Conway
Biohaven Pharmaceutical Holding Co Ltd.
Chief Scientific Officer
2018
John Tilton
Biohaven Pharmaceutical Holding Co Ltd.